Introduction
Pseudothrombocytopenia (PTCP) is a well-known phenomenon which is most commonly reflected by clumping of platelets in EDTA and rarely in citrate, or in the presence of IgM autoantibodies to platelets [1] [2] [3] [4] . Its pathogenesis, incidence, and association with diseases have been extensively discussed [5] [6] [7] [8] .
Salama Transfus Med Hemother 2015;42:345-348 346 observed to be 61,000/μl without treatment (table 2) . In 2010, a bleeding tendency developed, and the platelet count increased from 4,000/μl to more than 100,000/μl following treatment. IgG autoantibodies to the platelet glycoprotein IIb/IIIa were detected on patients' platelets by MAIPA, but not in the serum. In 2013, the patient developed autoimmune hemolytic anemia of the warm type (Evans syndrome) and her platelet count increased from 10,000/μl to a maximum of 320,000/μl following treatment with elthrombopag, whereas low-dose prednisolone and azathioprine remained ineffective. An EDTA-dependent PTCP was unexpectedly detected in 2014. This was observed to change to citrate and time-dependent PTCP in 2015 ( fig. 1 ). It remains unclear whether the thrombocytopenia diagnosed in 2004 is somewhat related to EDTA.
Discussion
The PTCP described here was rather obscure in regards to various aspects. It was complicated with ITP which is per se characterized by thrombocytopenia. The question whether PTCP was already present prior to the manifestation of ITP or developed during observation independent of ITP remains speculative. However, its long-lasting nature appears to be reflected by an association rather than a coincidence. This question has previously been discussed in Arth = Arthritis; Anast = anastrozole; Blt = bleeding tendency; Cand = candesartan; Diclo = diclofenac; Ena = enalapril; HTC = hydrochlorothiazide; Hyp = hypertension; Hypo = hypothyreosis; ITP = autoimmune thrombocytopenia; IVIgG = intravenous IgG; L-Thyr = L-thyroxine; Meto = metoprolole; MTX = methotrexate; Neb = Nebivolol; n.t. = not tested or unknown; Plab = platelet antibodies; Pltr = Platelet range; Pred = prednisolone; PS = psoriasis; PTCP = pseudothrombocytopenia; Rami = ramipril; Simva = simvastatine; Sul = sulfasalazine; Thrp = thrombocytopenia; Verap = verapamil; (+) = weak aggregates; + = significant aggregates. *Immediately after phlebotomy. **30 min after phlebotomy (see fig. 1 ). ***Platelet antibodies of IgM-and of IgG-classes. The former antibodies appeared to be related to citrate (fluorescence test), and the later antibodies to platelet antigens. two patients who were receiving heparin and developed anti-PF4 IgM antibodies. In both cases, platelet aggregation was dependent on the antibodies, resulting in the question of whether the concomitance was reflected by a coincidence or an association [17] . In contrast, a true association could be demonstrated in two other patients who had heparin-induced thrombocytopenia and PTCP [18] . In our patients, PTCP was independent of the true platelet count and ITP. This finding may reflect rather a coincidence than an association. On the other hand, the long-lasting course of both ITP and PTCP do support rather an association than an unexpected coincidence. Another possible explanation might be that the PTCP in the first patient was related rather to the psoriasis than to the ITP. This notion is supported by the clinical course of the patient and by a previous report describing PTCP in a patient with a medical history of benign psoriasis [20] . Though no association was discussed in that report, an association cannot be excluded.
Another strange aspect is the switch from EDTA-to citrate-dependent PTCP in both patients. The mechanism by which this switch may operate remain obscure. For the most part, EDTA is responsible for the vast majority of PTCPs, and citrate is used to disclose this phenomenon. Correspondingly, this was, in fact, initially the case in our patients. The reason for the switch described here remains unclear.
Most intriguingly, the PTCP in case 1 was not only anticoagulant-dependent but also EDTA-and time-dependent. This finding could be proven by repeated platelet counting using identical blood samples. This phenomenon has not yet been described in PTCP. Usually, clumping of platelets in the presence of EDTA is inversely related to the length of time elapsed since phlebotomy [9, 20] .
We recommend to consider PTCP not only in the list of ITP differential diagnosis but to also include ITP in the list of diseases associated with PTCP. In addition, PTCP may alter its appearance over time. Recently, Nagler et al. [22] have described a typical histogram of PTCP in an EDTA sample as compared to normal histogram in a citrated sample of the same patient. Ultimately the use of CTP (citrate, pyridoxal 5 -phosphate and Tris) as anticoagulant may be helpful in suspected cases.
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